Skip to content
10-Q

Quarterly Report

ACCENTIA BIOPHARMACEUTICALS INC

0001193125-12-234732

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Apr 30, 2012 81.18M sh
Capex Q2 2012 · Mar 31, 2012 $122.36K
Capex Q2 2012 · Mar 31, 2011 $149.8K
Operating Cash Flow Q2 2012 · Mar 31, 2012 −$2.79M
Operating Cash Flow Q2 2012 · Mar 31, 2011 −$2.48M
Cash And Equivalents Q2 2012 · Mar 31, 2012 $1.88M
Cash And Equivalents Q2 2012 · Sep 30, 2011 $420.54K
Cash And Equivalents Q2 2012 · Mar 31, 2011 $2.53M
Cash And Equivalents Q2 2012 · Sep 30, 2010 $558.45K
Stockholders Equity Q2 2012 · Mar 31, 2012 −$69.68M
Stockholders Equity Q2 2012 · Sep 30, 2011 −$74.56M
Current Liabilities Q2 2012 · Mar 31, 2012 $58.86M
Current Liabilities Q2 2012 · Sep 30, 2011 $31.27M
Total Liabilities Q2 2012 · Mar 31, 2012 $88.97M
Total Liabilities Q2 2012 · Sep 30, 2011 $92.97M
Current Assets Q2 2012 · Mar 31, 2012 $3.12M
Current Assets Q2 2012 · Sep 30, 2011 $2.87M
Total Assets Q2 2012 · Mar 31, 2012 $4.63M
Total Assets Q2 2012 · Sep 30, 2011 $5.91M
Sga Expense Q2 2012 · Mar 31, 2012 $3.95M
Sga Expense Q2 2012 · Mar 31, 2012 $4.95M
Sga Expense Q2 2012 · Mar 31, 2011 $3.7M
Sga Expense Q2 2012 · Mar 31, 2011 $15.9M
Rd Expense Q2 2012 · Mar 31, 2012 $1.81M
Rd Expense Q2 2012 · Mar 31, 2012 $2.77M
Rd Expense Q2 2012 · Mar 31, 2011 $417.85K
Rd Expense Q2 2012 · Mar 31, 2011 $711.65K
Operating Income Q2 2012 · Mar 31, 2012 −$5.41M
Operating Income Q2 2012 · Mar 31, 2012 −$6.81M
Operating Income Q2 2012 · Mar 31, 2011 −$3.61M
Operating Income Q2 2012 · Mar 31, 2011 −$15.78M
Gross Profit Q2 2012 · Mar 31, 2012 $424.42K
Gross Profit Q2 2012 · Mar 31, 2012 $1.02M
Gross Profit Q2 2012 · Mar 31, 2011 $563.81K
Gross Profit Q2 2012 · Mar 31, 2011 $921.83K
Cost Of Revenue Q2 2012 · Mar 31, 2012 $793.96K
Cost Of Revenue Q2 2012 · Mar 31, 2012 $1.43M
Cost Of Revenue Q2 2012 · Mar 31, 2011 $656.55K
Cost Of Revenue Q2 2012 · Mar 31, 2011 $1.21M
Revenue Q2 2012 · Mar 31, 2012 $1.22M
Revenue Q2 2012 · Mar 31, 2012 $2.45M
Revenue Q2 2012 · Mar 31, 2011 $1.22M
Revenue Q2 2012 · Mar 31, 2011 $2.13M